Neuromodulation to modulate glymphatic clearance
US12005251B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2022 |
| Grant date | Jun 11, 2024 |
| Priority date | — |
| Expiry date | Aug 10, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/37516
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention provides materials and methods for using electrical stimulation to treat a mammal having a proteinopathy (e.g., neurodegenerative diseases) or at risk of developing a proteinopathy are provided. For example, the present invention provides materials and methods for modulating glymphatic clearance (e.g., enhancing glymphatic clearance) of pathogenic proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.